News

Indianapolis Breast Center is claimed to be one of the first centers in Indiana to offer dedicated breast care diagnostics, including breast MR. Brad Hummel, CEO of Solis

Approximately 412 patients with osteoarthritis participated in this pivotal study. Final data indicate that the Remoxy study achieved a statistically significant result in its primary endpoint, the decrease

In this double-masked, prospective, randomized, multi-center Phase II age-related macular degeneration (AMD) trial, 157 patients were randomized to five dose groups and treated with vascular endothelial growth factor

Asmanex is indicated for the maintenance treatment of asthma as prophylactic therapy in patients four years of age and older, and is said to be the first and

The trial has been designed as a Phase III study in two parts. Part A will determine the feasibility of laromustine (Cloretazine) administration at three possible dose levels

The newest member to the family of Draeger anesthesia machines is said to be designed specifically to meet the requirements for the magnetic resonance imaging (MRI) environment. According

Mr Lombardi succeeds Stan Lapidus who will continue as chairman of the board of Helicos. Mr Lombardi, who will retain the position of president, has served as president

Under the terms of the agreement, ArunA has acquired an exclusive worldwide license to develop and commercialize human mesenchymal cells (hMSC) derived from human embryonic stem cells. ArunA

The core of the pilot line, comprising a Haake twin-screw compounding extruder and Nissei 20T injection molder, enables the production of high-quality drug loaded polymeric devices. This addition